Status: Recruiting
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
The purpose of this study is to determine if an investigational drug can prevent Bronchopulmonary Dysplasia, reducing the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.
Participants needed: 338
Trial details
Phase: Phase 2Age: 0-24Biological sex: AllType: InterventionalSponsor: OHB Neonatology Ltd.Updated: Jun 11, 2026Locations: 72
Eligibility criteria
Written informed consents and/or assents must be signed and dated by the partici... [+2]
Detectable major (or severe) congenital malformation identified before randomiza... [+8]